Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in individuals 18 years and older

Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in individuals 18 years and older

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older. This decision was based on scientific evidence, including initial data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease,…

Health Canada authorized two more COVID-19 vaccines

Health Canada authorized two more COVID-19 vaccines

Today, Health Canada authorized two vaccines; the COVID-19 vaccine manufactured by AstraZeneca, and developed in partnership with Oxford University, and, the Serum Institute of India’s version of the AstraZeneca vaccine.  Health Canada received an application for authorization from AstraZeneca on October 1, 2020, and from Verity Pharmaceuticals Inc./Serum Institute of India (in partnership with AstraZeneca Canada Inc.)…

Where and when will I get my COVID-19 vaccine in Quebec?

Where and when will I get my COVID-19 vaccine in Quebec?

This has been the question on everyones mind for the last few months. The Province of Quebec have been extremely slow on information on how and when the Quebec population will be receiving the COVID-19 vaccine. A shortage of COVID-19 vaccinations have held up the Quebec government and is the main reason single doses were…

COVID-19 vaccine 95% effective seeking approval for use

COVID-19 vaccine 95% effective seeking approval for use

Pfizer has released a statement saying their vaccine is 95% effective and they are seeking approval for distribution to the elder who are most at risk of dying from the virus. Pfizer have not release any trial information from studies and the results have not been tested or analyzed by any independent experts. The Canadian…

Canada signs agreement for 76M doses of potential COVID-19 vaccine

Canada signs agreement for 76M doses of potential COVID-19 vaccine

Canada has signed an agreement in principle for 76 million doses of a potential COVID-19 vaccine from Novavax, a biotechnology company in the USA. The promising results from a small clinical trial, released at the beginning of August, showed that the vaccine produced higher levels of antibodies in healthy volunteers after two doses, than those…